Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
Status:
Completed
Trial end date:
2019-08-13
Target enrollment:
Participant gender:
Summary
This phase II trial studies the side effects and how well pazopanib hydrochloride works in
treating patients with advanced thyroid cancer. Pazopanib hydrochloride may stop the growth
of tumor cells by blocking some of the enzymes needed for cell growth and by stopping blood
flow to the tumor.